Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies
Stopped early · Phase 2
Conditions studied: Relapsed/Refractory Waldenstrom Macroglobulinemia, Relapsed/Refractory Richter Transformation, Relapsed/Refractory Burkitt Lymphoma, Relapsed/Refractory Hairy Cell Leukemia
In brief
Master protocol: The goal of this master clinical study is to test how well the study drug, brexucabtagene autoleucel, works in participants with rare B-cell malignancies: relapsed/refractory Waldenstrom macroglobulinemia (r/r WM) (Substudy A), r/r Richter transformation (RT) (Substudy B), r/r Burkitt lymphoma (BL) (Substudy C) and r/r hairy cell leukemia (HCL) (Substudy D).
Key facts
- Study ID
- NCT05537766
- Run by
- Kite, A Gilead Company
- People needed
- 19
- Starts
- 2022-11-01
- Expected to finish
- 2025-01-27
- Last updated by the study team
- 2026-03-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- City of Hope (City of Hope National Medical Center) — Duarte, California, United States
- Stanford Cancer Institute — Stanford, California, United States
- Colorado Blood Cancer Institute — Denver, Colorado, United States
- Georgetown University Medical Centre — Washington D.C., District of Columbia, United States
- University of Iowa — Iowa City, Iowa, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- Hackensack University Medical Center — Hackensack, New Jersey, United States
- The Ohio State University Wexner Medical Center - James Cancer HospitalS — Columbus, Ohio, United States
- UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania, United States
- Tennessee Oncology, PLLC — Nashville, Tennessee, United States
- Vanderbilt University — Nashville, Tennessee, United States
- MD Anderson Cancer Center — Houston, Texas, United States
- Medical University of Vienna, Department of Internal Medicine I, Div. of Hematology — Vienna, Austria
- Hopital de la Pitie Salpetriere — Paris, France
- Centre hospitalier de Toulouse - Hematology department — Toulouse, France
- Universitatsklinikum Koln — Cologne, Germany
- Universitatsklinikum Heidelberg — Heidelberg, Germany
- Universitatsklinikum Ulm — Ulm, Germany
- IRCCS Azienda Ospedaliero - Universitaria di Bologna — Bologna, Italy
- ASST Grande Ospedale Metropolitano Niguarda — Milan, Italy
- Azienda Ospedale di Perugia - Ospedale S. Maria della Misericordia — Perugia, Italy
- Radboud University Nijmegen Medical Centre — Nijmegen, Netherlands
- Hospital Clinic de Barcelona — Barcelona, Spain
- Hospital Universitario de Salamanca — Salamanca, Spain
- Hospital Universitario Virgen del Rocio — Seville, Spain
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.